Prostate Cancer Reports
54

Volume 5 Number 7
July 2017



Home > Prostate Cancer Reports > Volume 5, Year 2017 > Number 7, July


CONTENTS



DIAGNOSIS AND EVALUATION
FOLLOW-UP AND QUALITY OF LIFE
INTEGRATIVE MEDICINE
PROGNOSIS
TREATMENT





DIAGNOSIS AND EVALUATION



Habl G, Sauter K, Schiller K, Dewes S, Maurer T, Eiber M, Combs SE.
68 Ga-PSMA-PET for radiation treatment planning in prostate cancer recurrences after surgery: Individualized medicine or new standard in salvage treatment.
Prostate. 2017 Jun;77(8):920-927. doi: 10.1002/pros.23347. Epub 2017 Mar 20.
Source | Abstract | Full text | Similar articles




Hofman MS, Iravani A.
Gallium-68 Prostate-Specific Membrane Antigen PET Imaging.
PET Clin. 2017 Apr;12(2):219-234. doi: 10.1016/j.cpet.2016.12.004. Epub 2017 Feb 1.
Source | Abstract | Full text | Similar articles




Hoyle AP, Clarke NW.
Magnetic Resonance Imaging and Detection of Metastases in Prostate Cancer: Learning Lessons from History.
Eur Urol. 2017 Jun 8. pii: S0302-2838(17)30492-X. doi: 10.1016/j.eururo.2017.05.052. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kallur KG, Ramachandra PG, Rajkumar K, Swamy SS, Desai I, Rao RM, Patil SG, Sridhar PS, Madhusudhan N, Krishnappa RS, Bhadrasetty V, Kumara HM, Santhosh SD, Ajaikumar BS.
Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.
Indian J Nucl Med. 2017 Apr-Jun;32(2):110-117. doi: 10.4103/0972-3919.202255.
Source | Abstract | Full text | Similar articles




Nguyen PL, Haddad Z, Ross AE, Martin NE, Deheshi S, Lam LLC, Chelliserry J, Tosoian JJ, Lotan TL, Spratt DE, Stoyanova RS, Punnen S, Ong K, Buerki C, Aranes M, Kolisnik T, Margrave J, Yousefi K, Choeurng V, Davicioni E, Trock BJ, Kane CJ, Pollack A, Davis JW, Feng FY, Klein EA.
Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.
Eur Urol. 2017 May 18. pii: S0302-2838(17)30390-1. doi: 10.1016/j.eururo.2017.05.009. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Osman MM, Iravani A, Hofman MS, Hicks RJ.
Detection of Synchronous Primary Malignancies with 68Ga-PSMA PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients.
J Nucl Med. 2017 Jun 1. pii: jnumed.117.190215. doi: 10.2967/jnumed.117.190215. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Pourmand G, Gooran S, Hossieni SR, Guitynavard F, Safavi M, Sharifi A, Mokhtari E.
Correlation of Preoperative and Radical Prostatectomy Gleason Score: Examining the Predictors of Upgrade and Downgrade Results.
Acta Med Iran. 2017 Apr;55(4):249-253.
Source | Abstract | Full text | Similar articles




Simopoulos DN, Natarajan S, Jones TA, Fendler WP, Sisk AE Jr, Marks LS.
Targeted Prostate Biopsy Using 68Gallium PSMA-PET/CT for Image Guidance.
Urol Case Rep. 2017 Jun 3;14:11-14. doi: 10.1016/j.eucr.2017.05.006. eCollection 2017 Sep.
Source | Abstract | Full text | Similar articles




Uprimny C, Kroiss AS, Fritz J, Decristoforo C, Kendler D, von Guggenberg E, Nilica B, Maffey-Steffan J, di Santo G, Bektic J, Horninger W, Virgolini IJ.
Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.
Eur J Nucl Med Mol Imaging. 2017 Jun 6. doi: 10.1007/s00259-017-3743-z. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Uprimny C.
68Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?
Wien Med Wochenschr. 2017 Jun 2. doi: 10.1007/s10354-017-0569-z. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





FOLLOW-UP AND QUALITY OF LIFE



Jang JW, Drumm MR, Efstathiou JA, Paly JJ, Niemierko A, Ancukiewicz M, Talcott JA, Clark JA, Zietman AL.
Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade.
Cancer Med. 2017 May 31. doi: 10.1002/cam4.1103. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





INTEGRATIVE MEDICINE



Dasari S, Ali SM, Zheng G, Chen A, Dontaraju VS, Bosland MC, Kajdacsy-Balla A, Munirathinam G.
Vitamin K and its analogs: Potential avenues for prostate cancer management.
Oncotarget. 2017 May 19. doi: 10.18632/oncotarget.17997. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Liu VWS, Yau WL, Tam CW, Yao KM, Shiu SYW.
Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and NF-κB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-Resistant Prostate Cancer (CRPC) Therapy.
Int J Mol Sci. 2017 May 31;18(6). pii: E1130. doi: 10.3390/ijms18061130.
Source | Abstract | Full text | Similar articles




Pounis G, Tabolacci C, Costanzo S, Cordella M, Bonaccio M, Rago L, D'Arcangelo D, Filippo Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L, Facchiano F; Moli-sani study investigators.
Reduction by coffee consumption of prostate cancer risk: Evidence from the Moli-sani cohort and cellular models.
Int J Cancer. 2017 Jul 1;141(1):72-82. doi: 10.1002/ijc.30720. Epub 2017 Apr 24.
Source | Abstract | Full text | Similar articles





PROGNOSIS



Albertsen PC.
Re: 10-Year Outcomes After Monitoring, Surgery or Radiotherapy for Localized Prostate Cancer.
Eur Urol. 2017 Jun 8. pii: S0302-2838(17)30485-2. doi: 10.1016/j.eururo.2017.05.045. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hegde JV, Veruttipong D, Said JW, Reiter RE, Steinberg ML, King CR, Kishan AU.
Prostate Cancer Antigen 3 (PCA3) Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-Free Survival in Clinically-Localized, Intermediate- and High-Risk Prostate Cancer.
Urology. 2017 May 25. pii: S0090-4295(17)30565-4. doi: 10.1016/j.urology.2017.05.028. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Feldman AS, Meyer CP, Sanchez A, Krasnova A, Reznor G, Menon M, Kibel AS, Choueiri TK, Lipsitz SR, Sun M, Trinh QD.
Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population-Based Analysis Comparing Radical Prostatectomy Versus External Beam Radiation.
J Urol. 2017 May 25. pii: S0022-5347(17)74504-1. doi: 10.1016/j.juro.2017.05.073. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kweldam CF, Kümmerlin IP, Nieboer D, Steyerberg EW, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ.
Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.
Mod Pathol. 2017 May 19. doi: 10.1038/modpathol.2017.29. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Miyoshi Y, Yoneyama S, Kawahara T, Hattori Y, Teranishi JI, Ohta JI, Takebayashi S, Yokomizo Y, Hayashi N, Uemura H.
Prediction of Time to Castration-Resistant Prostate Cancer Using Bone Scan Index in Men with Metastatic Hormone-Sensitive Prostate Cancer.
Urol Int. 2017 Jun 14. doi: 10.1159/000477131. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Nunez Bragayrac LA, Murekeyisoni C, Vacchio MJ, Attwood K, Mehedint DC, Mohler JL, Azabdaftari G, Xu B, Kauffman EC.
Blinded review of archival radical prostatectomy specimens supports that contemporary Gleason score 6 prostate cancer lacks metastatic potential.
Prostate. 2017 Jul;77(10):1076-1081. doi: 10.1002/pros.23364. Epub 2017 May 26.
Source | Abstract | Full text | Similar articles




Roux V, Eyraud R, Brureau L, Gourtaud G, Senechal C, Fofana M, Blanchet P.
[Impact of Gleason score on biochemical recurrence free survival after radical prostatectomy with positive surgical margins].
Prog Urol. 2017 Jun - Jul;27(8-9):467-473. doi: 10.1016/j.purol.2017.05.003. Epub 2017 May 30. French.
Source | Abstract | Full text | Similar articles




Teloken PE, Li J, Woods CG, Cohen RJ.
The impact of prostate cancer zonal origin on pathological parameters at radical prostatectomy and subsequent biochemical failure.
J Urol. 2017 May 26. pii: S0022-5347(17)74541-7. doi: 10.1016/j.juro.2017.05.075. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Tumati V, Jackson WC, Abugharib AE, Raj G, Roehrborn C, Lotan Y, Courtney K, Bagrodia A, Gahan JC, Zumsteg ZS, Folkert MR, Laine AM, Hannan R, Spratt DE, Desai NB.
Natural History of 'Second' Biochemical Failure Following Salvage Radiation Therapy for Prostate Cancer: A Multi-Institution Study.
BJU Int. 2017 Jun 5. doi: 10.1111/bju.13926. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





TREATMENT



Anantharaman A, Small EJ.
Tackling non-metastatic castration-resistant prostate cancer: special considerations in treatment.
Expert Rev Anticancer Ther. 2017 Jul;17(7):625-633. doi: 10.1080/14737140.2017.1333903. Epub 2017 May 31.
Source | Abstract | Full text | Similar articles




Dess RT, Morgan TM, Nguyen PL, Mehra R, Sandler HM, Feng FY, Spratt DE.
Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer.
Curr Urol Rep. 2017 Jul;18(7):55. doi: 10.1007/s11934-017-0700-0.
Source | Abstract | Full text | Similar articles




Habl G, Straube C, Schiller K, Duma MN, Oechsner M, Kessel KA, Eiber M, Schwaiger M, Kübler H, Gschwend JE, Combs SE.
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT).
BMC Cancer. 2017 May 22;17(1):361. doi: 10.1186/s12885-017-3341-2.
Source | Abstract | Full text | Similar articles




Lange JM, Trock BJ, Gulati R, Etzioni R.
A Framework for Treatment Decision Making at Prostate Cancer Recurrence.
Med Decis Making. 2017 May 31:272989X17711913. doi: 10.1177/0272989X17711913. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Miszczyk L, Namysł Kaletka A, Napieralska A, Woźniak G, Stąpór Fudzińska MA, Głowacki G, Tukiendorf A.
Cyberknife Radioablation of Prostate Cancer – Preliminary Results for 400 Patients
Asian Pac J Cancer Prev. 2017 Apr 1;18(4):1007-1013.
Source | Abstract | Full text | Similar articles




Sita TL, Petras KG, Wafford QE, Berendsen MA, Kruser TJ.
Radiotherapy for cranial and brain metastases from prostate cancer: a systematic review.
J Neurooncol. 2017 May 25. doi: 10.1007/s11060-017-2460-6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Wallis CJD, Glaser A, Hu JC, Huland H, Lawrentschuk N, Moon D, Murphy DG, Nguyen PL, Resnick MJ, Nam RK.
Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review.
Eur Urol. 2017 Jun 10. pii: S0302-2838(17)30495-5. doi: 10.1016/j.eururo.2017.05.055. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Yang DD, Muralidhar V, Mahal BA, Nezolosky MD, Labe SA, Vastola ME, Boldbaatar N, King MT, Martin NE, Orio PF 3rd, Choueiri TK, Trinh QD, Den RB, Spratt DE, Hoffman KE, Feng FY, Nguyen PL.
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy.
Urol Oncol. 2017 May 19. pii: S1078-1439(17)30190-4. doi: 10.1016/j.urolonc.2017.04.018. [Epub ahead of print]
Source | Abstract | Full text | Similar articles